SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: NNBP - Nanobac Pharmaceuticals Inc. (Bulls Board)

06 Feb 2007 12:18 PM
16 Nov 2006 01:54 PM
02 Nov 2006 08:50 AM
04 Oct 2006 10:56 AM
25 Sep 2006 10:43 AM
19 Sep 2006 05:30 PM <--
14 Sep 2006 12:14 PM
22 Aug 2006 05:14 PM
28 May 2006 09:50 PM
27 May 2006 10:46 PM
23 May 2006 05:30 PM

Return to NNBP - Nanobac Pharmaceuticals Inc. (Bulls Board)
 
TAMPA, Fla., Sep 12, 2006 (BUSINESS WIRE) -- Nanobac Pharmaceuticals, Inc. (OTCBB: NNBP) ("Nanobac" or "the Company") today announced the release of an analytical profile on the Company, by respected micro-cap analyst Mr. Paul Silver, Director of Research for Wall Street Resources, Inc., which contains a short-term target value for NNBP of $0.91 per share. Report wallstreetresources.net .
Shares Outstanding 193.51M Float 83.77M DD details tinyurl.com
Web site nanobac.com.

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News